Критерії вибору методу реваскуляризації міокарда в пацієнтів зі стабільною ішемічною хворобою серця у клінічній практиці

О.А. Єпанчінцева, О.Й. Жарінов, К.О. Міхалєв, А.В. Хохлов, Б.М. Тодуров

Література 

1. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2014;35:2541–2619.
2. Doherty J, Kort S, Mehran R. et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Nuc. Cardiol. 2017;24(5):1759–1792.
3. Abu Daya H, Hage F. Guidelines in review: ACC/AATS/AHA/ASE/ ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease. J Nucl Cardiol. 2017;24(5):1793–1799.
4. Fihn S, Gardin J, Abrams J. et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):e44–e164.
5. Fihn S, Blankenship J, Alexander K. et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64(18):1929–1949.
6. Kurlansky Р, Herbert M, Prince S, Mack M. Coronary bypass versus percutaneous intervention: sex matters. The impact of gender on long-term outcomes of coronary revascularization. Eur J Cardiothorac Surg. 2017;51(3):554–561.
7. Sanchez C, Dota A, Badhwar V. et al. Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease. Catheter Cardiovasc Interv. 2016;88(4):E103–E112.
8. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J. 2013;34:2949–3003.
9. Pelegrino V, Dantas R, Clark A. Health-related quality of life determinants in outpatients with heart failure. Rev Latino-Am Enfermagem. 2011;19(3):451–457.
10. Hak T, Willems D, van der Wal G, Visser F. A qualitative validation of the Minnesota Living with Heart Failure Questionnaire. Qual Life Res. 2004;13(2):417–426.
11. Ware J, Sherbourne C. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
12. Nogueira I, Servantes D, Nogueira P. et al. Correlation between quality of life and functional capacity in cardiac failure. Arq Bras Cardiol. 2010;95(2):238–243.
13. KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.
14. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;18(8):891–975.
15. Mancini G, Farkouh M, Brooks M. et al. Medical Treatment and revascularization options in patients with type 2 diabetes and coronary disease. J Am Coll Cardiol. 2016;68(10):985–995.
16. Mancini G, Farkouh M, Verma S. Revascularization for patients with diabetes mellitus and stable ischemic heart disease: an update. Curr Opin Cardiol. 2017;32(5):608–616.
17. Giustino G, Dangas G. Surgical revascularization versus percutaneous coronary intervention and optimal medical therapy in diabetic patients with multi-vessel coronary artery disease. Prog Cardiovasc Dis. 2015;58(3):306–315.
18. Mavromatis K, Samady H, King S. et al. Revascularization in patients with diabetes: PCI or CABG or none. Curr Cardiol Rep. 2015;17(3):565.
19. Tu B, Rich B, Labos C, Brophy J. Coronary revascularization in diabetic patients a systematic review and bayesian network meta-analysis. Ann Intern Med. 2014;161(10):724–732.
20. Kulik A. Quality of life after coronary artery bypass graft surgery versus percutaneous coronary intervention: what do the trials tell us? Curr Opin Cardiol. 2017;32(6):707–714.
21. Takousi M, Schmeer S, Manaras I. et al. Health-Related quality of life after coronary revascularization: A systematic review with meta-analysis. Hellenic J Cardiol. 2016. pii: S1109-9666(16)30145-2.
22. Posenau J, Wojdyla D, Shaw L. et al. Revascularization strategies and outcomes in elderly patients with multivessel coronary disease. Ann Thorac Surg. 2017;104(1):107–115.